Furthermore, abnormal expression of the protein tyrosine phosphatase, non-receptor type 22 (PTPN22) gene leading to hypercitrullination of proteins can increase the propensity for NET formation, which is not uncommon in seropositive RA patients (50, 51). This evidence concerns the gene PTPN22 and rheumatoid arthritis.